BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tripathi A, Vana PG, Chavan TS, Brueggemann LI, Byron KL, Tarasova NI, Volkman BF, Gaponenko V, Majetschak M. Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function. Proc Natl Acad Sci U S A 2015;112:E1659-68. [PMID: 25775528 DOI: 10.1073/pnas.1417564112] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Anderson CA, Solari R, Pease JE. Biased agonism at chemokine receptors: obstacles or opportunities for drug discovery? J Leukoc Biol 2016;99:901-9. [PMID: 26701135 DOI: 10.1189/jlb.2MR0815-392R] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
2 Wong YM, LaPorte HM, Albee LJ, Baker TA, Bach HH 4th, Vana PG, Evans AE, Gamelli RL, Majetschak M. Ubiquitin Urine Levels in Burn Patients. J Burn Care Res 2017;38:e133-43. [PMID: 26204385 DOI: 10.1097/BCR.0000000000000278] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Evans AE, Tripathi A, LaPorte HM, Brueggemann LI, Singh AK, Albee LJ, Byron KL, Tarasova NI, Volkman BF, Cho TY, Gaponenko V, Majetschak M. New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle. Int J Mol Sci 2016;17:E971. [PMID: 27331810 DOI: 10.3390/ijms17060971] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
4 Nassoiy SP, Babu FS, LaPorte HM, Majetschak M. Pharmacological modulation of C-X-C motif chemokine receptor 4 influences development of acute respiratory distress syndrome after lung ischaemia-reperfusion injury. Clin Exp Pharmacol Physiol 2018;45:16-26. [PMID: 28815665 DOI: 10.1111/1440-1681.12845] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
5 Desantis AJ, Weche M, Enten GA, Gao X, Majetschak M. The Chemokine (C-C Motif) Receptor 2 Antagonist INCB3284 Reduces Fluid Requirements and Protects From Hemodynamic Decompensation During Resuscitation From Hemorrhagic Shock. Critical Care Explorations 2022;4:e0701. [DOI: 10.1097/cce.0000000000000701] [Reference Citation Analysis]
6 Gao X, Enten GA, DeSantis AJ, Volkman BF, Gaponenko V, Majetschak M. Characterization of heteromeric complexes between chemokine (C-X-C motif) receptor 4 and α1-adrenergic receptors utilizing intermolecular bioluminescence resonance energy transfer assays. Biochem Biophys Res Commun 2020;528:368-75. [PMID: 32085899 DOI: 10.1016/j.bbrc.2020.02.094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Mani BK, Robakowski C, Brueggemann LI, Cribbs LL, Tripathi A, Majetschak M, Byron KL. Kv7.5 Potassium Channel Subunits Are the Primary Targets for PKA-Dependent Enhancement of Vascular Smooth Muscle Kv7 Currents. Mol Pharmacol 2016;89:323-34. [PMID: 26700561 DOI: 10.1124/mol.115.101758] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
8 Kleinau G, Müller A, Biebermann H. Oligomerization of GPCRs involved in endocrine regulation. J Mol Endocrinol 2016;57:R59-80. [PMID: 27151573 DOI: 10.1530/JME-16-0049] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
9 Gao X, Abdelkarim H, Albee LJ, Volkman BF, Gaponenko V, Majetschak M. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3. PLoS One 2018;13:e0204041. [PMID: 30248140 DOI: 10.1371/journal.pone.0204041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 DeSantis AJ, Enten GA, Gao X, Majetschak M. Chemokine receptor antagonists with α1-adrenergic receptor blocker activity. J Basic Clin Physiol Pharmacol 2021. [PMID: 34144642 DOI: 10.1515/jbcpp-2020-0523] [Reference Citation Analysis]
11 Walsh SK, Lipina C, Ang SY, Sato M, Chia LY, Kocan M, Hutchinson DS, Summers RJ, Wainwright CL. GPR55 regulates the responsiveness to, but does not dimerise with, α1A-adrenoceptors. Biochem Pharmacol 2021;188:114560. [PMID: 33844984 DOI: 10.1016/j.bcp.2021.114560] [Reference Citation Analysis]
12 Scofield SL, Amin P, Singh M, Singh K. Extracellular Ubiquitin: Role in Myocyte Apoptosis and Myocardial Remodeling. Compr Physiol 2015;6:527-60. [PMID: 26756642 DOI: 10.1002/cphy.c150025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
13 Bach HH 4th, Wong YM, LaPorte HM, Gamelli RL, Majetschak M. Pharmacological targeting of chemokine (C-X-C motif) receptor 4 in porcine polytrauma and hemorrhage models. J Trauma Acute Care Surg 2016;80:102-10. [PMID: 26683396 DOI: 10.1097/TA.0000000000000865] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
14 Tripathi A, Gaponenko V, Majetschak M. Commercially available antibodies directed against α-adrenergic receptor subtypes and other G protein-coupled receptors with acceptable selectivity in flow cytometry experiments. Naunyn Schmiedebergs Arch Pharmacol 2016;389:243-8. [PMID: 26660071 DOI: 10.1007/s00210-015-1196-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
15 Albee LJ, Eby JM, Tripathi A, LaPorte HM, Gao X, Volkman BF, Gaponenko V, Majetschak M. α1-Adrenergic Receptors Function Within Hetero-Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C-X-C motif) Receptor 4 in Vascular Smooth Muscle Cells. J Am Heart Assoc 2017;6:e006575. [PMID: 28862946 DOI: 10.1161/JAHA.117.006575] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
16 Evans AE, Vana PG, LaPorte HM, Kennedy RH, Gamelli RL, Majetschak M. Cardiovascular Responsiveness to Vasopressin and α1-Adrenergic Receptor Agonists After Burn Injury. J Burn Care Res 2017;38:90-8. [PMID: 28045780 DOI: 10.1097/BCR.0000000000000374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
17 Enten GA, Gao X, Strzelinski HR, Weche M, Liggett SB, Majetschak M. α1B/D-adrenoceptors regulate chemokine receptor-mediated leukocyte migration via formation of heteromeric receptor complexes. Proc Natl Acad Sci U S A 2022;119:e2123511119. [PMID: 35537053 DOI: 10.1073/pnas.2123511119] [Reference Citation Analysis]
18 Gao X, Albee LJ, Volkman BF, Gaponenko V, Majetschak M. Asymmetrical ligand-induced cross-regulation of chemokine (C-X-C motif) receptor 4 by α1-adrenergic receptors at the heteromeric receptor complex. Sci Rep 2018;8:2730. [PMID: 29426850 DOI: 10.1038/s41598-018-21096-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
19 Babu FS, Liang X, Enten GA, DeSantis AJ, Volkman BF, Gao X, Majetschak M. Natural and engineered chemokine (C-X-C motif) receptor 4 agonists prevent acute respiratory distress syndrome after lung ischemia-reperfusion injury and hemorrhage. Sci Rep 2020;10:11359. [PMID: 32647374 DOI: 10.1038/s41598-020-68425-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Heuninck J, Perpiñá Viciano C, Işbilir A, Caspar B, Capoferri D, Briddon SJ, Durroux T, Hill SJ, Lohse MJ, Milligan G, Pin JP, Hoffmann C. Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3. Mol Pharmacol 2019;96:778-93. [PMID: 31092552 DOI: 10.1124/mol.118.115477] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
21 Oishi A, Karamitri A, Gerbier R, Lahuna O, Ahmad R, Jockers R. Orphan GPR61, GPR62 and GPR135 receptors and the melatonin MT2 receptor reciprocally modulate their signaling functions. Sci Rep 2017;7:8990. [PMID: 28827538 DOI: 10.1038/s41598-017-08996-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
22 Gao X, Cheng YH, Enten GA, DeSantis AJ, Gaponenko V, Majetschak M. Regulation of the thrombin/protease-activated receptor 1 axis by chemokine (CXC motif) receptor 4. J Biol Chem 2020;295:14893-905. [PMID: 32839271 DOI: 10.1074/jbc.RA120.015355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
23 Gao X, Enten GA, DeSantis AJ, Majetschak M. Class A G protein-coupled receptors assemble into functional higher-order hetero-oligomers. FEBS Lett 2021;595:1863-75. [PMID: 34032285 DOI: 10.1002/1873-3468.14135] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Albee LJ, LaPorte HM, Gao X, Eby JM, Cheng YH, Nevins AM, Volkman BF, Gaponenko V, Majetschak M. Identification and functional characterization of arginine vasopressin receptor 1A : atypical chemokine receptor 3 heteromers in vascular smooth muscle. Open Biol 2018;8:170207. [PMID: 29386406 DOI: 10.1098/rsob.170207] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
25 Ji Y, Yao J, He Y. Extracellular ubiquitin protects cardiomyocytes during ischemia/hypoxia by inhibiting mitochondrial apoptosis pathway through CXCR4. Biomed Pharmacother 2020;131:110787. [PMID: 33152945 DOI: 10.1016/j.biopha.2020.110787] [Reference Citation Analysis]
26 Hughes CE, Nibbs RJB. A guide to chemokines and their receptors. FEBS J 2018;285:2944-71. [PMID: 29637711 DOI: 10.1111/febs.14466] [Cited by in Crossref: 228] [Cited by in F6Publishing: 217] [Article Influence: 57.0] [Reference Citation Analysis]
27 Cai X, Bai B, Zhang R, Wang C, Chen J. Apelin receptor homodimer-oligomers revealed by single-molecule imaging and novel G protein-dependent signaling. Sci Rep 2017;7:40335. [PMID: 28091541 DOI: 10.1038/srep40335] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
28 Gallo M, Navarro G, Franco R, Andreu D. A2A Receptor Homodimer-Disrupting Sequence Efficiently Delivered by a Protease-Resistant, Cyclic CPP Vector. Int J Mol Sci 2019;20:E4937. [PMID: 31590403 DOI: 10.3390/ijms20194937] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 Kleist AB, Getschman AE, Ziarek JJ, Nevins AM, Gauthier PA, Chevigné A, Szpakowska M, Volkman BF. New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model. Biochem Pharmacol 2016;114:53-68. [PMID: 27106080 DOI: 10.1016/j.bcp.2016.04.007] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 10.8] [Reference Citation Analysis]
30 Pawig L, Klasen C, Weber C, Bernhagen J, Noels H. Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives. Front Immunol 2015;6:429. [PMID: 26347749 DOI: 10.3389/fimmu.2015.00429] [Cited by in Crossref: 99] [Cited by in F6Publishing: 92] [Article Influence: 14.1] [Reference Citation Analysis]
31 Eby JM, Abdelkarim H, Albee LJ, Tripathi A, Gao X, Volkman BF, Gaponenko V, Majetschak M. Functional and structural consequences of chemokine (C-X-C motif) receptor 4 activation with cognate and non-cognate agonists. Mol Cell Biochem 2017;434:143-51. [PMID: 28455789 DOI: 10.1007/s11010-017-3044-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
32 O'Sullivan KM, Ford SL, Longano A, Kitching AR, Holdsworth SR. Intrarenal Toll-like receptor 4 and Toll-like receptor 2 expression correlates with injury in antineutrophil cytoplasmic antibody-associated vasculitis. Am J Physiol Renal Physiol 2018;315:F1283-94. [PMID: 29923769 DOI: 10.1152/ajprenal.00040.2018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
33 Zha D, Cheng H, Li W, Wu Y, Li X, Zhang L, Feng YH, Wu X. High glucose instigates tubulointerstitial injury by stimulating hetero-dimerization of adiponectin and angiotensin II receptors. Biochem Biophys Res Commun 2017;493:840-6. [PMID: 28870804 DOI: 10.1016/j.bbrc.2017.08.047] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
34 Tarasov SG, Dyba M, Yu J, Tarasova N. Design and Generation of Self-Assembling Peptide Virus-like Particles with Intrinsic GPCR Inhibitory Activity. Methods Mol Biol 2021;2208:135-48. [PMID: 32856260 DOI: 10.1007/978-1-0716-0928-6_9] [Reference Citation Analysis]
35 Gomes I, Ayoub MA, Fujita W, Jaeger WC, Pfleger KD, Devi LA. G Protein-Coupled Receptor Heteromers. Annu Rev Pharmacol Toxicol 2016;56:403-25. [PMID: 26514203 DOI: 10.1146/annurev-pharmtox-011613-135952] [Cited by in Crossref: 168] [Cited by in F6Publishing: 140] [Article Influence: 24.0] [Reference Citation Analysis]
36 Cheng YH, Eby JM, LaPorte HM, Volkman BF, Majetschak M. Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function. PLoS One 2017;12:e0187949. [PMID: 29125867 DOI: 10.1371/journal.pone.0187949] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
37 Boule LA, Ju C, Agudelo M, Parira T, Cannon A, Davis B, Eby J, Cresci G, Samuelson DR, Shukla P, Alrefai WA, Sureshchandra S, Pandey SC, Schnabl B, Curtis BJ, Wyatt TA, Choudhry MA, Kovacs EJ. Summary of the 2016 Alcohol and Immunology Research Interest Group (AIRIG) meeting. Alcohol 2018;66:35-43. [PMID: 29127885 DOI: 10.1016/j.alcohol.2017.07.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Grozdanovic M, Laffey KG, Abdelkarim H, Hitchinson B, Harijith A, Moon HG, Park GY, Rousslang LK, Masterson JC, Furuta GT, Tarasova NI, Gaponenko V, Ackerman SJ. Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness. J Allergy Clin Immunol 2019;143:669-680.e12. [PMID: 29778505 DOI: 10.1016/j.jaci.2018.05.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
39 Jung H, Mithal DS, Park JE, Miller RJ. Localized CCR2 Activation in the Bone Marrow Niche Mobilizes Monocytes by Desensitizing CXCR4. PLoS One 2015;10:e0128387. [PMID: 26029924 DOI: 10.1371/journal.pone.0128387] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
40 Gaitonde SA, González-Maeso J. Contribution of heteromerization to G protein-coupled receptor function. Curr Opin Pharmacol 2017;32:23-31. [PMID: 27835800 DOI: 10.1016/j.coph.2016.10.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 6.3] [Reference Citation Analysis]
41 Tarakanov AO, Fuxe K. The triplet puzzle theory indicates extensive formation of heteromers between opioid and chemokine receptor subtypes. J Neural Transm (Vienna) 2015;122:1509-14. [PMID: 26133164 DOI: 10.1007/s00702-015-1421-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
42 Elmansi AM, Awad ME, Eisa NH, Kondrikov D, Hussein KA, Aguilar-Pérez A, Herberg S, Periyasamy-Thandavan S, Fulzele S, Hamrick MW, McGee-Lawrence ME, Isales CM, Volkman BF, Hill WD. What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands.Pharmacol Ther. 2019;198:90-108. [PMID: 30759373 DOI: 10.1016/j.pharmthera.2019.02.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
43 Albee LJ, Gao X, Majetschak M. Plasticity of seven-transmembrane-helix receptor heteromers in human vascular smooth muscle cells. PLoS One 2021;16:e0253821. [PMID: 34166476 DOI: 10.1371/journal.pone.0253821] [Reference Citation Analysis]
44 Kwon EK, Min CK, Kim Y, Lee JW, Aigerim A, Schmidt S, Nam HJ, Han SK, Kim K, Cha JS, Kim H, Kim S, Cho HS, Choi MS, Cho NH. Constitutive activation of T cells by γ2-herpesviral GPCR through the interaction with cellular CXCR4. Biochim Biophys Acta Mol Cell Res 2017;1864:1-11. [PMID: 27751885 DOI: 10.1016/j.bbamcr.2016.10.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]